Main Street Research LLC Bristol Myers Squibb CO Transaction History

Main Street Research LLC

$1.54 Billion
Q4 2024

A detailed history of Main Street Research LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Main Street Research LLC holds 15,257 shares of BMY stock, worth $867,360. This represents 0.06% of its overall portfolio holdings.

Number of Shares

15,257

Previous 15,232 0.16%

Holding current value

$867,360

Previous $788,000 9.39%

% of portfolio

0.06%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$51.92 - $59.94 $1,298 - $1,498	25 Added 0.16%	15,257 $862,000
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $95,183 - $124,200	-2,400 Reduced 13.61%	15,232 $788,000
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $39,686 - $52,248	-986 Reduced 5.3%	17,632 $732,000
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $114,144 - $129,417	-2,379 Reduced 11.33%	18,618 $1.01 Million
Q1 2023 May 01, 2023	SELL	$65.71 - $74.53 $88,774 - $100,690	-1,351 Reduced 6.05%	20,997 $1.46 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $4,177 - $4,946	61 Added 0.27%	22,348 $1.61 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $20 - $12,294	160 Added 0.72%	22,287 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $7,262 - $7,998	100 Added 0.45%	22,127 $1.7 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $19,550 - $23,442	-318 Reduced 1.42%	22,027 $1.61 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $82,804 - $96,530	-1,544 Reduced 6.46%	22,345 $1.39 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $16,567 - $19,406	-280 Reduced 1.16%	23,889 $1.41 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $1,052 - $1,146	-17 Reduced 0.07%	24,169 $1.62 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $52,871 - $59,465	-891 Reduced 3.55%	24,186 $1.53 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $63,629 - $72,103	-1,102 Reduced 4.21%	25,077 $1.56 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $95,678 - $106,024	-1,666 Reduced 5.98%	26,179 $1.58 Million
Q2 2020 Jul 29, 2020	SELL	$54.82 - $64.09 $47,145 - $55,117	-860 Reduced 3.0%	27,845 $1.64 Million
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $5,660 - $8,226	-122 Reduced 0.42%	28,705 $1.6 Million
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $74,257 - $96,862	1,509 Added 5.52%	28,827 $1.85 Million
Q3 2019 Oct 21, 2019	SELL	$42.77 - $50.71 $25,662 - $30,426	-600 Reduced 2.15%	27,318 $1.39 Million
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $29,003 - $32,071	-650 Reduced 2.28%	27,918 $1.27 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 0.7%	28,568 $1.77 Million
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $119,402 - $148,821	-2,363 Reduced 7.59%	28,768 $1.59 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $74,900 - $86,225	1,250 Added 4.18%	31,131 $1.97 Million
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $46,273 - $50,450	-772 Reduced 2.52%	29,881 $1.83 Million
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $1.69 Million - $1.95 Million	30,653	30,653 $1.95 Million

Others Institutions Holding BMY

# of Institutions

2,639

Shares Held

1.46B

Call Options Held

31.5M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Research LLC with notifications on news.

Account

Main Street Research LLC Bristol Myers Squibb CO Transaction History